NanoString Technologies Stock News

Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered into a credit agreement with its existing le

Investors looking at today's price action in NanoString (NASDAQ: NSTG ) stock ought to be shaking their heads in amazement. Indeed, after announcing the company would be filing for bankruptcy protecti

NanoString Technologies (NASDAQ: NSTG ) stock is taking a beating on Monday after the company announced a voluntary Chapter 11 bankruptcy filing. NanoString Technologies notes that this bankruptcy fi

Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is sch

Playing in the field of nano-cap stocks is similar to the concept of stealing bases. In a tight baseball game, every advantage counts.

SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.

NanoString Technologies, Inc. (NASDAQ:NSTG ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Doug Farrell - IR Brad Gray - President and CEO Tom Bailey - CFO Conferen

While the top- and bottom-line numbers for NanoString (NSTG) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics co

In stock trading, shorting is seen as a high-risk, high-reward strategy. This approach involves borrowing stocks, selling them, and betting on their price dropping to make a profit.

According to NanoString (NSTG), SMI's unique ability to interrogate both RNA and proteins at ultra-high plex with subcellular resolution has made it a one-of-a-kind tool.

NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through the nCounter Human Organ Transplant Panel.

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is sch

NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations & Corporate Communication

The action is hot in Helen Of Troy NASDAQ: HELE and NanoString Technologies NASDAQ: NSTG. These unrelated companies issued better-than-expected results and guidance that have their shares up double-di